LENZ Therapeutics Inc (LENZ) — Defensive Interval Ratio
LENZ Therapeutics Inc (LENZ) has a Defensive Interval Ratio of 4644 days as of December 2025. Defensive assets of $269.60 Million (cash $-, short-term investments $267.17 Million, receivables $2.43 Million) cover 4644 days of daily cash needs of $58.05K/day. See how liquid is LENZ Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
LENZ Therapeutics Inc Defensive Interval Ratio (2022–2025)
This chart shows how LENZ Therapeutics Inc's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 4644 days, meaning defensive assets of $269.60 Million can fund 4644 days of operations without new revenue. See LENZ Therapeutics Inc net asset quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for LENZ Therapeutics Inc (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for LENZ Therapeutics Inc from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see LENZ Therapeutics Inc (LENZ) market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 4644 days | $269.60 Million | $58.05K/day | $- | $267.17 Million | ▼ -1980 days |
| 2024 | 6625 days | $188.87 Million | $28.51K/day | $- | $188.87 Million | ▲ +6021 days |
| 2023 | 604 days | $30.65 Million | $50.72K/day | $- | $30.65 Million | ▼ -7868 days |
| 2022 | 8473 days | $220.50 Million | $26.02K/day | $- | $220.50 Million | — |